White House: It is unacceptable for states to restrict access to abortion pills

Published Date: 08 Mar 2023

The White House said Friday it was "dangerous and unacceptable" for elected officials to target women's access to federally-approved abortion pills.

Read Full News

Latest News

US Supreme Court Extends Pause on Decision Narrowing Abortion Pill Access

The U.S. Supreme Court on Monday extended a pause on a ruling that would curb the abortion pill mifepristone from being ⁠prescribed through telemedicine and dispensed...

Treatment of Vulvodynia Differs by Race and Ethnicity

The reasons for the disparities are not clear, but they point to the complexity of the diagnosis and the different ways patients may describe pain and symptoms.

Maternal Endometriosis Tied to Birth Defects

Endometriosis in mothers is associated with an increased risk for congenital anomalies in their infants.

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Latest News

The U.S. Supreme Court on Monday extended a pause on a ruling that would curb the abortion pill mifepristone from being ⁠prescribed through telemedicine and dispensed...

The reasons for the disparities are not clear, but they point to the complexity of the diagnosis and the different ways patients may describe pain and symptoms.

Endometriosis in mothers is associated with an increased risk for congenital anomalies in their infants.

Unpacking Emerging Evidence and Addressing Complex Questions in HER2+ Early Breast Cancer Office Hours

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

News All Time

Former UCLA Gynecologist Pleads Guilty to Sex Abuse After Conviction Was Overturned

The plea was unexpected

HHS Changing Its Tune on Contraceptive Access

Focus of Title X program shifting to "natural family planning" and encouragement of pregnancy

High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents

Also from SGO: p53 reactivator active in advanced gynecologic cancers, "perfect" score in GTN

'Something Is Wrong': Don't Dismiss Pregnant Patients

Bias often shapes whose voices we prioritize and whose we question

Medical Board Sanctions Docs for Delayed Care That Led to Deaths of 2 Pregnant Women

Reproductive rights advocates said Texas board should do more

Advanced Ovarian Cancer Responds to Claudin-Targeted Drug in Preliminary Trial

Partial responses in half of patients with platinum-resistant disease, as crowded ADC list grows

Giving Flu, Pertussis Shots on the Same Day Likely Safe in Pregnancy

Pregnancy, birth, neonatal outcomes similar to when giving a single shot

Study on Maternal RSV Vaccine Flags Possible Risk, Calls for More Research

Analyses unable to rule out potential increase in pregnancy-associated hypertensive disorders

Kennedy Tangles With Lawmakers Over Vitamin K Shots, Vaccines for Newborns

"I've never been anti-vax," the health secretary said

More Granular Risk Score May Improve Maternal Morbidity Prediction

New maternal Prenatal Risk Index model weighs more factors based on severity of risk

Tumor DNA Clearance Before Breast Cancer Surgery Predicts Response, Metastasis Risk

Potential guidance for decisions about treatment escalation, de-escalation

FDA Staff Raises Concerns on Breast, Prostate Cancer Drug Applications

The Oncologic Drugs Advisory Committee will meet for the first time in 9 months

SCOTUS Sides With Anti-Abortion Center Raising 1st Amendment Fears About State Probe

Ruling does not resolve the underlying case

Understanding Treatment Strategies for HER2 Positive IHC3+ Metastatic Solid Tumors

Understanding Treatment Strategies for HER2 Positive IHC3+ Metastatic Solid Tumors

First-in-Class Vepdegestrant Approved in Advanced Breast Cancer

Oral agent in second-line more than doubled median PFS in patients with ESR1 mutations

FDA Panel Gives Thumbs Down to Novel Strategy for Switching Breast Cancer Therapy

Panelists conflicted about positive trial's ability to validate biomarker-guided switching

Recommended News For You

Durvalumab Wins FDA Approval in Limited-Stage SCLC

Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

Clinical trial could lead to new 'gold standard' test for prostate cancer detection

The Risk of Major Mortality is Associated with the Start of Opioids in Dementia.

Why breast cancer survivors don't take their medicine, and what can be done about it.

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

Recommended Articles For You

The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia 

Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies 

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System 

Understanding the Rare Disease: Werner Syndrome Explained  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Radiation therapy can promote amphiregulin, which increases growth of metastases

3.

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

4.

DNA origami offers more accurate imaging in the fight against pancreatic cancer

5.

Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?

1.

Colon Cancer Staging: What You Need to Know

2.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

3.

Understanding QSOFA: A Vital Tool for Recognizing Sepsis 

4.

Everything You Need to Know About HTLV: A Comprehensive Guide 

5.

Uncovering the Mysteries of the RDW Blood Test

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

4.

Understanding the causes of anemia in adults beyond nutritional deficiencies

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot